These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 20816818)

  • 1. Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.
    Mielcarek M; Storb R; Georges GE; Golubev L; Nikitine A; Hwang B; Nash RA; Torok-Storb B
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):214-25. PubMed ID: 20816818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation.
    Kornblit B; Leisenring WM; Santos EB; Storb R; Sandmaier BM
    Chimerism; 2013; 4(3):95-101. PubMed ID: 23723082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.
    Lee WS; Suzuki Y; Graves SS; Iwata M; Venkataraman GM; Mielcarek M; Peterson LJ; Ikehara S; Torok-Storb B; Storb R
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):465-75. PubMed ID: 20457265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.
    Ringdén O; Gustafsson B; Sadeghi B
    Front Immunol; 2020; 11():567210. PubMed ID: 33193339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation.
    Min CK; Kim BG; Park G; Cho B; Oh IH
    Bone Marrow Transplant; 2007 May; 39(10):637-45. PubMed ID: 17369865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
    Johnstone BH; Messner F; Brandacher G; Woods EJ
    Front Immunol; 2021; 12():622604. PubMed ID: 33732244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
    Storb R; Yu C; Barnett T; Wagner JL; Deeg HJ; Nash RA; Kiem HP; McSweeney P; Seidel K; Georges G; Zaucha JM
    Blood; 1999 Aug; 94(3):1131-6. PubMed ID: 10419907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice.
    Sudres M; Norol F; Trenado A; Grégoire S; Charlotte F; Levacher B; Lataillade JJ; Bourin P; Holy X; Vernant JP; Klatzmann D; Cohen JL
    J Immunol; 2006 Jun; 176(12):7761-7. PubMed ID: 16751424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
    Storb R; Raff RF; Appelbaum FR; Deeg HJ; Fitzsimmons W; Graham TC; Pepe M; Pettinger M; Sale G; van der Jagt R
    Transplantation; 1993 Oct; 56(4):800-7. PubMed ID: 7692635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
    Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
    Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
    Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.
    Chang J; Graves SS; Butts-Miwongtum T; Sale GE; Storb R; Mathes DW
    Transplantation; 2016 Dec; 100(12):e120-e127. PubMed ID: 27861292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.